ALPS Medical Breakthroughs ETF Rating $35.27 +0.80 (+2.32%) Closing price 08/22/2025 04:10 PM EasternExtended Trading$35.36 +0.09 (+0.25%) As of 08/22/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.95Holdings in SBIO have an aggregate rating of Moderate Buy based on 290 analyst ratings issued in the past year covering 25 companies (58.3% of the portfolio).SBIO Aggregate Price Target$35.27High Prediction$35.27Average Prediction$35.27Low Prediction$35.27Holdings in SBIO have an aggregate price target of $35.27 and a range of $35.27 to $35.27 covering 25 companies (58.3% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.69%RYTMRhythm Pharmaceuticals$103.27+1.6%3.8157 of 5 stars3.07$101.57 -1.6%15News Coverage3.37%RNAAvidity Biosciences$46.35+3.8%3.1709 of 5 stars3.06$67.00 44.6%18News CoveragePositive NewsInsider TradeOptions Volume3.13%AXSMAxsome Therapeutics$118.51+1.2%4.7934 of 5 stars3.07$178.00 50.2%15News CoveragePositive News3.07%NUVLNuvalent$76.08+3.3%3.3927 of 5 stars3.08$118.91 56.3%12News CoverageAnalyst ForecastInsider Trade2.87%MRUSMerus$67.49+1.3%2.3037 of 5 stars3.09$88.50 31.1%11News Coverage2.73%ALKSAlkermes$29.75+2.4%4.7287 of 5 stars2.83$41.08 38.1%12Trending NewsAnalyst Revision2.71%VKTXViking Therapeutics$26.00+1.3%3.9733 of 5 stars3.00$86.92 234.3%14Trending NewsAnalyst ForecastOptions Volume2.58%ACADACADIA Pharmaceuticals$25.74+3.9%3.9367 of 5 stars2.61$28.88 12.2%18Positive NewsInsider Trade2.50%KRYSKrystal Biotech$150.49+3.3%4.7268 of 5 stars3.00$210.38 39.8%9Trending NewsAnalyst Forecast2.48%CYTKCytokinetics$38.34+0.8%3.7139 of 5 stars2.93$71.58 86.7%15News Coverage2.41%ACLXArcellx$71.28-0.7%2.1228 of 5 stars3.13$114.31 60.4%15News CoveragePositive News2.34%PCVXVaxcyte$32.29+1.2%2.464 of 5 stars3.09$136.50 322.7%11News CoveragePositive News2.34%ZLABZai Lab$35.04+3.1%2.414 of 5 stars2.83$57.22 63.3%6News CoverageInsider Trade2.31%AKROAkero Therapeutics$49.23+1.9%4.0009 of 5 stars3.00$81.57 65.7%8News CoveragePositive News2.17%PTCTPTC Therapeutics$50.57+3.4%4.3662 of 5 stars2.63$69.15 36.7%16Trending NewsAnalyst ForecastAnalyst Revision2.11%MLTXMoonLake Immunotherapeutics$55.89+3.2%1.6291 of 5 stars2.78$74.43 33.2%92.04%PTGXProtagonist Therapeutics$57.48+2.6%1.9444 of 5 stars3.00$67.20 16.9%9Positive News1.96%MTSRMetsera$33.05+0.8%N/A3.00$55.00 66.4%5News Coverage1.93%MIRMMirum Pharmaceuticals$71.52+3.6%3.655 of 5 stars3.13$74.13 3.6%8News CoveragePositive News1.82%APLSApellis Pharmaceuticals$27.97+1.3%4.2463 of 5 stars2.58$34.12 22.0%19News CoverageInsider TradeShort Interest ↑1.70%NAMSNewAmsterdam Pharma$25.00+2.3%3.5536 of 5 stars2.89$41.20 64.8%91.67%XENEXenon Pharmaceuticals$38.84+1.7%2.0868 of 5 stars3.00$53.20 37.0%11News CoverageOptions Volume1.61%CRNXCrinetics Pharmaceuticals$30.92+5.2%3.6619 of 5 stars2.78$68.86 122.7%9News CoveragePositive NewsInsider Trade1.49%ARWRArrowhead Pharmaceuticals$21.33+2.8%3.6585 of 5 stars3.00$43.14 102.3%9Positive News1.31%TARSTarsus Pharmaceuticals$57.25+1.2%1.8866 of 5 stars3.00$66.67 16.4%7News CoveragePositive News This page (NYSEARCA:SBIO) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access